Found: 11
Select item for more details and to access through your institution.
Evaluation and use of an anti-cynomolgus monkey CD79b surrogate antibody-drug conjugate to enable clinical development of polatuzumab vedotin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34562-5
- By:
- Publication type:
- Article
Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates.
- Published in:
- Nucleic Acids Research, 2015, v. 43, n. 2, p. 1189, doi. 10.1093/nar/gku1362
- By:
- Publication type:
- Article
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates.
- Published in:
- Pharmaceutical Research, 2015, v. 32, n. 6, p. 1884, doi. 10.1007/s11095-014-1582-1
- By:
- Publication type:
- Article
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 184, doi. 10.1038/nbt.2108
- By:
- Publication type:
- Article
In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.
- Published in:
- Clinical & Experimental Metastasis, 2003, v. 20, n. 8, p. 745, doi. 10.1023/B:CLIN.0000006817.25962.87
- By:
- Publication type:
- Article
Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
- Published in:
- Clinical & Experimental Metastasis, 2003, v. 20, n. 8, p. 733, doi. 10.1023/B:CLIN.0000006815.49932.98
- By:
- Publication type:
- Article
Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 449, doi. 10.1002/ajh.26809
- By:
- Publication type:
- Article
Targeting LGR5<sup>+</sup> cells with an antibody-drug conjugate for the treatment of colon cancer.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 314, p. 1, doi. 10.1126/scitranslmed.aac7433
- By:
- Publication type:
- Article
Differential Effects of Predosing on Tumor and Tissue Uptake of an <sup>111</sup>In-Labeled Anti-TENB2 Antibody–Drug Conjugate.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1454, doi. 10.2967/jnumed.112.103168
- By:
- Publication type:
- Article
Imaging of bioluminescent LNCaP-luc-M6 Tumors: A new animal model for the study of metastatic human prostate cancer.
- Published in:
- Prostate, 2004, v. 59, n. 3, p. 292, doi. 10.1002/pros.20003
- By:
- Publication type:
- Article